Add BrightSurf on Google Email

NewYork-Presbyterian


Immune therapy can control fertility in mammals

Researchers have developed an immune therapy technique that can suppress fertility hormones in females and males, potentially preventing pregnancy. The treatment could be used on dogs, cats, and other mammals, as well as humans with hormonal imbalances or conditions such as androgen excess syndromes.

SourceNewYork-Presbyterian·JournalGenetic Engineering & Biotechnology News·DateMar 31, 2011

Simple blood test detects early emphysema in smokers before symptoms appear

A new blood test measures destruction of lung air sacs and can detect early emphysema in smokers, potentially preventing disease progression. The test is a low-cost screening tool that could help the 20% of American adults who smoke or are exposed to secondhand smoke understand their risk of developing this progressive lung disease.

SourceNewYork-Presbyterian·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateMar 11, 2011

Brain imaging provides window into consciousness

Researchers use fMRI to probe for higher-level cognitive functioning in severely brain-injured patients, finding a wide variation in response capabilities. The study suggests that no bedside exam can accurately assess cognitive function in these patients, highlighting the need for further exploration and understanding.

SourceNewYork-Presbyterian·JournalBrain·DateFeb 25, 2011

Vaccine blocks cocaine high in mice

Researchers have developed a lasting anti-cocaine immunity in mice using a safe vaccine combining bits of the common cold virus with a particle mimicking cocaine. The vaccine elicits an immune response that prevents cocaine molecules from reaching the brain, reducing hyperactivity.

SourceNewYork-Presbyterian·JournalMolecular Therapy·DateJan 4, 2011

Hormone's crucial role in 2 anemic blood disorders

Researchers found that boosting hepcidin levels may directly affect relieving anemic patients of their body's iron overload. Two studies illustrated a potential new dietary treatment for patients with hemochromatosis by increasing hepcidin levels and reducing iron absorption from the gut.

SourceNewYork-Presbyterian·JournalJournal of Clinical Investigation·DateNov 23, 2010

Hepatitis C study shows superior viral cure rate

A new study reveals that telaprevir significantly improves sustained viral response rates for first-time hepatitis C patients to 75%, even for African-Americans and those with advanced liver fibrosis. The regimen's shorter treatment time also produces lower discontinuation rates for side effects compared to standard therapy.

Potential new treatment for deadly nipah and hendra viruses identified by Weill Cornell researchers

Scientists at Weill Cornell Medical College have identified a potential new treatment for the Nipah and Hendra viruses, which are lethal and emerging viruses with no current treatment or vaccine available. The approach uses cholesterol-tagged peptides to target the membrane where the virus fuses with host cells, preventing infection.

SourceNewYork-Presbyterian·JournalPLOS Pathogens·DateOct 28, 2010

Cigarette smoke causes harmful changes in the lungs even at the lowest levels

A new study found that even low levels of secondhand smoke and infrequent smoking can cause harmful genetic changes in the lungs, leading to an increased risk of lung cancer and chronic obstructive pulmonary disease (COPD). The research suggests that no level of smoking or exposure to secondhand smoke is safe.

SourceNewYork-Presbyterian·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateAug 20, 2010

Researchers discover metabolic vulnerability in TB and potential drug target

A recent study published in PNAS reveals that Mycobacterium tuberculosis relies on gluconeogenic substrates for growth and persistence, with phosphoenolpyruvate carboxykinase (PEPCK) playing a pivotal role. This finding could lead to the development of new drug therapies targeting the enzyme, potentially improving treatment outcomes fo...

SourceNewYork-Presbyterian·JournalProceedings of the National Academy of Sciences·DateMay 10, 2010

New class of drug kills lymphoma cells

Researchers design compound that effectively blocks BCL6's cancer-causing actions, killing off cancer cells with minimal toxicity. The discovery opens possibilities for treating other tumor types and improving survival rates for patients with non-Hodgkin's lymphoma.

SourceNewYork-Presbyterian·JournalCancer Cell·DateApr 14, 2010